Hypocalcemia


Etiology

Pseudohypocalcemia

  • Interference with Colorimetric Laboratory Calcium Assay
    • Gadodiamide MRI Angiography Contrast
      • In Addition, Since the Contrast is Excreted Renally, it May Be Retained for Prolonged Periods After the MRI
    • Gadoversetamide MRI Angiography Contrast
      • In Addition, Since the Contrast is Excreted Renally, it May Be Retained for Prolonged Periods After the MRI

Low Parathyroid Hormone (Hypoparathyroidism) (see Hypoparathyroidism)

Genetic

  • Abnormal Parathyroid Gland Development
    • DiGeorge Syndrome
    • Mutations in the Transcription Factor Glial-Cell Missing B (GCMB)
  • Abnormal Parathyroid Hormone (PTH) Synthesis
  • Activating Mutations of Calcium-Sensing Receptor (CaSR)
    • Physiology
      • Activating Mutations of Calcium-Sensing Receptor (CaSR) Decrease the Set-Point of CaSR, So that Parathyroid Hormone (PTH) is Not Released at Serum Calcium Concentrations Which Would Normally Trigger Parathyroid Hormone (PTH) Release
    • Etiology
      • Autosomal Dominant Hypocalcemia
      • Sporadic Isolated Hypoparathyroidism
    • Diagnosis
      • Normal/High Urinary Calcium (Due to Increased Activation of CaSR in the Kidney)

Autoimmune

  • General Comments
    • Acquired Hypoparathyroidism Unrelated to Surgery is Most Commonly Due to Autoimmune Disease (Clin Exp Immunol, 1966) [MEDLINE] (Medicine-Baltimore, 1981) [MEDLINE]
  • Polyglandular Autoimmune Syndrome Type I (see xxxx)
    • Epidemiology
      • Familial
    • Clinical
      • Chronic Mucocutaneous Candidiasis (see Candida)
        • Typical Onset in Childhood
      • Hypoparathyroidism
        • Typical Onset Several Years After Childhood
      • Primary Adrenal Insufficiency (see Adrenal Insufficiency)
        • Typical Onset in Adolescence
  • Isolated Hypoparathyroidism Due to Activating Antibodies to Calcium-Sensing Receptor (CaSR)

Postoperative

  • General Comments
    • Surgical Etiologies are the Most Common Causes of Hypoparathyroidism
    • Postoperative Hypoparathyroidism Can Be Trasient (with Recovery in Days-Months), Intermittent, or Permanent
      • Transient Hypoparathyroidism May Be Due to Manipulation of the Blood Supply to the Parathyroid Gland or Removal or One or More of the Parathyroid Glands
      • Intermittent Hypoparathyroidism May Be Due to Decreased Parathyroid Reserve
  • Parathyroidectomy (see Parathyroidectomy)
    • Post-Parathyroidectomy Hypoparathyroidism May Be Transient (Due to Suppression of the Remaining Parathyroid Tissue by Prior Hypercalcemia) or May Be Severe/Prolonged (in Cases of Hungry Bone Syndrome)
      • See Hungry Bone Syndrome Below
  • Radical Neck Dissection (for Head and Neck Cancer) (see xxxx)
  • Thyroidectomy (see Thyroidectomy)
    • Transient Hypoparathyroidism Occurs in Up to 20% of Patients After Surgery for Thyroid Cancer
    • Permanent Hypoparathyroidism Occurs in 0.8-3% of Patients After Total Thyroidectomy (Especially When the Goiter is Extensive and Anatomical Landmarks are Obscured)

Infiltration of Parathyroid Gland

  • Granulomatous Infiltration of Parathyroid Gland
    • Epidemiology
      • Rare
  • Hemochromatosis (see Hemochromatosis)
    • Epidemiology
      • Rare (J Bone Miner Metab, 2006) [MEDLINE] (Pediatr Endocrinol Rev, 2007) [MEDLINE]
  • Metastases to Parathyroid Gland
    • Epidemiology
      • Rare (Br J Hosp Med, 1990) [MEDLINE]
      • Most Commonly Associated with Metastases (Typically in the Setting of Widely Metastatic Disease) from Breast Cancer, Lung Cancer, and Melanoma (Head Neck Pathol, 2018) [MEDLINE]
  • Wilson Disease (see Wilson Disease)
    • Epidemiology

Other

  • Chronic Respiratory Alkalosis (see Respiratory Alkalosis)
    • Physiology
      • Chronic Respiratory Alkalosis Causes Relative Hypoparathyroidism and Renal Resistance to Parathyroid Hormone (PTH), Resulting in Hypercalciuria and Decreased Ionized Calcium Concentration
  • Radiation-Induced Destruction of Parathyroid Gland
    • Epidemiology
      • Rare
  • Human Immunodeficiency Virus (HIV) (see Human Immunodeficiency Virus)
    • Epidemiology
      • Case Reports (Bone Rep, 2021) [MEDLINE]
  • Hungry Bone Syndrome (Post-Parathyroidectomy) (see Parathyroidectomy)
    • Diagnosis
      • Parathyroid Hormone (PTH) May Be Decreased, Normal, or Increased
    • Clinical
    • Treatment
      • Hypocalcemia May Persist Despite Recovery of Parathyroid Hormone (PTH) Secretion from the Remaining Normal Parathyroid Glands
  • Hypomagnesemia (see Hypomagnesemia)
    • Epidemiology
      • Interestingly, a Few Patients with Magnesium-Responsive Hypocalcemia But Normal Serum Magnesium Levels Have Also Been Reported
    • Physiology
      • Hypomagnesemia Can Cause Parathyroid Hormone (PTH) Resistance (When Serum Magnesium Decreases to <0.8 mEq/L (1 mg/dL, 0.4 mmol/L)
      • Hypomagnesemia Can Decrease Parathyroid Hormone (PTH) Secretion (When Hypomagnesemia is More Severe)
    • Diagnosis
      • Parathyroid Hormone (PTH) Level is Low/Normal/High
      • Most Patients Have Low-Normal Serum Phosphate Levels (Likely Due to Poor Phosphate Intake)
    • Treatment
      • Hypomagnesemia-Related Hypocalcemia Requires Magnesium Replacement to Raise the Serum Calcium Level
  • Severe Hypermagnesemia (see Hypermagnesemia)
    • Epidemiology
      • Rare Etiology of Hypocalcemia
      • Occurs in the Setting o Serum Magnesium Concentration >5 mEq/L (6 mg/dL, 2.5 mmol/L)
        • These Levels May Be Seen in the Setting of Magnesium Therapy for the Treatment of Preeclampsia (see Preeclampsia/Eclampsia)
        • These Levels May Be Seen in the Setting of Magnesium Therapy for the Treatment of Subarachnoid Hemorrhage (SAH) (see Subarachnoid Hemorrhage) (Neurocrit Care, 2008) [MEDLINE]
    • Physiology
      • Suppression of Parathyroid Hormone (PTH) Secretion (NEJM, 1984) [MEDLINE]
    • Clinical
      • Clinically Symptomatic Hypocalcemia is Rarely Occurs, Due to it Short Duration and the Antagonistic Neuromuscular Effects of Hypermagnesemia

High Parathyroid Hormone (Secondary Hyperparathyroidism in Response to Hypocalcemia) (see Hyperparathyroidism)

Vitamin D Deficiency/Resistance (see Vitamin D)

  • Etiology
    • Nutritional Vitamin D Deficiency with Associated Decreased Cutaneous Vitamin D Synthesis
    • Vitamin D Deficiency Due to Abnormal Synthesis and Catabolism
      • Chronic Kidney Disease (CKD) (see Chronic Kidney Disease)
        • Low Calcitriol (1,25 Dihydroxyvitamin D) Production Due to Decreased Glomerular Filtration Rate, Loss of the 1-Alpha-Hydroxylase Enzyme Secondary to Structural Renal Disease, and Suppression of Enzyme Activity Due to Hyperphosphatemia and Resultant Increased Circulating FGF23 Levels
      • Drugs (Inducers of P450 Enzyme, Which Metabolizes Calcidiol to Inactive Vitamin D Metabolites)
      • Cirrhosis/Liver Disease (see Cirrhosis)
      • Nephrotic Syndrome (see Nephrotic Syndrome)
        • Due to Loss of Calcidiol (25-Hydroxyvitamin D) Bound to Vitamin D-Binding Protein
      • Vitamin D-Dependent Rickets Type I
    • Vitamin D Resistance
      • Hereditary Vitamin D-Resistant Rickets (HVDRR)
  • Physiology
    • Decreased Synthesis or Action of Vitamin D, Resulting in Hypocalcemia with a High Parathyroid Hormone (PTH) Level

Parathyroid Hormone (PTH) Resistance

  • Chronic Respiratory Alkalosis (see Respiratory Alkalosis)
    • Physiology
      • Chronic Respiratory Alkalosis Causes Relative Hypoparathyroidism and Renal Resistance to Parathyroid Hormone (PTH), Resulting in Hypercalciuria and Decreased Ionized Calcium Concentration
  • Hypomagnesemia (see Hypomagnesemia)
    • Epidemiology
      • Interestingly, a Few Patients with Magnesium-Responsive Hypocalcemia But Normal Serum Magnesium Levels Have Also Been Reported
    • Physiology
      • Hypomagnesemia Can Cause Parathyroid Hormone (PTH) Resistance (When Serum Magnesium Decreases to <0.8 mEq/L (1 mg/dL, 0.4 mmol/L)
      • Hypomagnesemia Can Decrease Parathyroid Hormone (PTH) Secretion (When Hypomagnesemia is More Severe)
    • Diagnosis
      • Parathyroid Hormone (PTH) Level is Low/Normal/High
      • Most Patients Have Low-Normal Serum Phosphate Levels (Likely Due to Poor Phosphate Intake)
    • Treatment
      • Hypomagnesemia-Related Hypocalcemia Requires Magnesium Replacement to Raise the Serum Calcium Level
  • Missense Mutation in Parathyroid Hormone
  • Pseudohypoparathyroidism

Renal Disease

  • Acute Kidney Injury (AKI) (see Acute Kidney Injury)
  • Chronic Kidney Disease (CKD) (see Chronic Kidney Disease)
    • Epidemiology
      • Hypocalcemia Does Not Occur Until the Glomerular Filtration Rate (GFR) Falls to <15 mL/min (or Treatment by Dialysis)
      • Chronic Kidney Disease is the Most Common Etiology of an Acquired Decrease in 1,25-Dihydroxyvitamin D Production
    • Physiology
      • Decrease in Renal Production of 1,25-Dihydroxyvitamin D
      • Hyperphosphatemia (Due to Decreased Fractional Excretion of Phosphorus) Also Contributes to Development of Hypocalcemia (see Hyperphosphatemia)

Loss of Calcium from Circulation

  • Acute Pancreatitis (see Acute Pancreatitis)
    • Epidemiology
      • Prospective Study of Hypocalcemia in Patients with Acute Pancreatitis (Ann Gastroenterol, 2016) [MEDLINE]
        • Approximately 35.2% of Patients Had Hypocalcemia
    • Mechanisms
      • Saponification of Calcium Soaps within the Inflamed Pancreas and Abdominal Cavity (J Bone Miner Res, 1990) [MEDLINE]
    • Diagnosis
      • Parathyroid Hormone (PTH) Levels are Typically Elevated (But May Be Variable) (Br J Surg, 1994) [MEDLINE]
    • Clinical
      • Prospective Study of Hypocalcemia in Patients with Acute Pancreatitis (Ann Gastroenterol, 2016) [MEDLINE]
        • Approximately 35.2% of Patients Had Hypocalcemia
        • Patients with Hypocalcemia Had Significantly Higher Frequency of Persistent Organ Failure, Mortality, and Need for Intervention (P<0.05)
        • Approximately 32.4% of the Patients with Hypocalcemia Had Tetany
        • Patients with Tetany Had Significantly Lower Serum Corrected Calcium and Ionized Calcium Levels, as Compared to Patients with Asymptomatic Hypocalcemia (P<0.05)
        • Patients with Tetany Had Significantly Higher Mortality Rates, as Compared to Patients with Asymptomatic Hypocalcemia (100% vs. 8%; P = 0.00001) as Well as Persistent Organ Failure (100% vs. 32%; P = 0.000006)
  • Acute Respiratory Alkalosis (see Respiratory Alkalosis)
    • Mechanisms
      • Acute Respiratory Alkalosis Increases Calcium Binding to Albumin, Decreasing the Free (Ionized) Calcium Concentration
  • Acute Severe Illness/Sepsis (see Sepsis)
    • Epidemiology
      • Hypocalcemia is Common in the Setting of Critical Illness or Postoperative State (Approaching 80-90% of Cases) (Ann Intern Med, 1987) [MEDLINE] (Am J Med, 1988) [MEDLINE] (Am J Kidney Dis, 2001) [MEDLINE]
    • Commonly Associated Etiologies
    • Mechanisms (Ann Intern Med, 1987) [MEDLINE] (Am J Med, 1988) [MEDLINE]
      • Decreased Calcitriol Production (Due to Hypomagnesemia and Actions of Inflammatory Cytokines on the Kidneys)
      • Decreased Parathyroid Hormone (PTH) Secretion (Due to Hypomagnesemia and Actions of Inflammatory Cytokines on the Parathyroid Glands)
      • End-Organ Parathyroid Hormone (PTH) Resistance (Due to Hypomagnesemia and Actions of Inflammatory Cytokines on the Kidneys and Bone)
  • Hyperphosphatemia (see Hyperphosphatemia)
    • Etiology of Acute Hyperphosphatemia
      • Burns (Severe) (see Burns)
        • Hyperphosphatemia is Associated with Increased Mortality Rate in Patients with Burns (PLoS One, 2018) [MEDLINE]
      • Increased Phosphate Intake in the Setting of Renal Failure
        • Phosphate Enemas
        • Oral Phosphate Replacement
      • Rhabdomyolysis (see Rhabdomyolysis)
        • Patients are Typically Hypocalcemic During the Oliguric Phase of Acute Kidney Injury (Due to Acute Tubular Necrosis)
      • Tumor Lysis Syndrome (see Tumor Lysis Syndrome)
        • Tumor Cells Have 4x as Much Phosphate as Normal Cells
        • When the Calcium Concentration Times the Phosphate Concentration (Calcium Phosphate Product) is >60 mg2/dL2, There is an Increased Risk of Calcium Phosphate Precipitation in the Renal Tubules (Which Can Result in Acute Kidney Injury) and the Heart (Which Can Result in Arrhythmias)
        • Renal Replacement Therapy (Dialysis) May be Required if the Calcium Phosphate Product is ≥70 mg2/dL2
    • Etiology of Chronic Hyperphosphatemia
      • Decreased Phosphate Clearance Due to Chronic Kidney Disease
        • Results in Chronic Hyperphosphatemia, Causing Hypocalcemia
        • In These Cases, Primary Impairment of Calcitriol Synthesis (Resulting in Decreased Intestinal Calcium Absorption) Further Exacerbates the Hypocalcemia
    • Mechanisms
      • Hyperphosphatemia Results in Calcium Deposition, Mostly in Bone (But Also in Extraskeletal Tissues)
  • Osteoblastic Bone Metastases
    • Etiology
      • Breast Cancer (see Breast Cancer)
      • Prostate Cancer (see Prostate Cancer)
        • In a Study of Advanced Prostate Cancer (n = 131), 34% of Patients Had Elevated Parathyroid Hormone (PTH) Levels and 56% Had Decreased Ionized Calcium Levels (J Clin Endocrinol Metab, 2001) [MEDLINE]
    • Mechanisms
      • Due to Deposition of Calcium in the Newly Formed Bone Around the Tumor (Am J Med, 1981) [MEDLINE] (J Clin Endocrinol Metab, 2001) [MEDLINE]

Drugs/Toxins

Inhibitors of Bone Resorption

  • Bisphosphonates (see Bisphosphonates)
    • Epidemiology
      • Hypocalcemia is More Frequently Seen When Potent Bisphosphonates (Such as Zoledronate) are Used and in Patients with Underlying Vitamin D Deficiency, Unrecognized Hypoparathyroidism, or Chronic Kidney Disease
    • Pharmacology
      • Bisphosphonates Reduce Osteoclastic Bone Resorption
  • Calcitonin (see Calcitonin)
    • Pharmacology
      • Peptide Sequence Similar to Human Calcitonin
      • Antagonizes the Effects of Parathyroid Hormone (PTH)
      • Directly Inhibits Osteoclastic Bone Resorption
      • Decreases Renal Tubular Absorption of Calcium/Phosphate/Sodium/Potassium/Magnesium, Resulting in Increased Renal Excretion
      • Increases Jejunal Secretion of Water/Sodium/Potassium/Chloride
  • Denosumab (Xgeva, Prolia) (see Denosumab)
    • Pharmacology
      • Denosumab is a Fully Human Monoclonal Antibody to the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL), Which is an Osteoclast Differentiating Factor

Other Drugs/Toxins

  • 5-Fluorouracil (5-FU) and Leucovorin (see 5-Fluorouracil)
    • Epidemiology
      • Hypocalcemia Occurs in Approximately 65% of Cases
    • Physiology
      • Probably Due to a Decrease in Calcitriol Production
  • Calcium Chelators
    • Ethylenediaminetetraacetic Acid (EDTA) (see Ethylenediaminetetraacetic Acid)
    • Citrate (see Citrate)
      • Massive Blood Product Transfusion (Especially in the Setting of Trauma) (see Packed Red Blood Cells) (World J Surg, 2020) [MEDLINE]
        • Due to Citrate Binding of Calcium
        • In Cases Due to Large-Volume Blood Product Transfusion, Total Calcium May Be Normal, But Ionized Calcium is Decreased
        • Hypocalcemia is Usually Transient
      • Plasmapheresis (see Plasmapheresis)
        • Hypocalcemia is Common During Plasmapheresis
    • Phosphate
  • Cinacalcet (Sensipar) (see Cinacalcet)
    • Pharmacology
      • Cinacalcet is a Calcimimetic Drug
  • Fluoride Intoxication (see Fluoride)
    • Physiology
      • Formation of Fluorapatite
  • Foscarnet (Foscavir) (see Foscarnet)
    • Physiology
      • Due to Intravascular Complexing of Foscarnet with Calcium
  • Lenvatinib (Lenvima) (see Lenvatinib)
    • Physiology
      • Tyrosine Kinase Inhibitor Which Induces Hypocalcemia Via Parathyroid Hormone Dependent and Parathyroid Hormone-Independent Mechanisms (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • Sorafenib (Nexavar) (see Sorafenib)
    • Physiology
      • Tyrosine Kinase Inhibitor (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • Vandetanib (Caprelsa) (see Vandetanib)
    • Physiology
      • Tyrosine Kinase Inhibitor Which Induces Hypocalcemia Via Parathyroid Hormone Dependent and Parathyroid Hormone-Independent Mechanisms (Ann Endocrinol-Paris, 2023) [MEDLINE]
  • White Phosphorus Toxicity (see White Phosphorus)
    • Epidemiology
      • Associated with Systemic Toxicity
    • Clinical
      • Hypocalcemia in the Setting of White Phosphorus Toxicity May Be Severe

Other

  • Dengue (see Dengue Virus)
    • Epidemiology
      • Dengue Fever Has Been Associated with Hypocalcemia (Int J Crit Illn Inj Sci, 2014) [MEDLINE]
    • Physiology
      • Likely Multifactorial
    • Clinical
      • As Suggested in In Vitro Studies, Derangements of Calcium Homeostasis are Likely to Be Associated with Myocardial Dysfunction and Cardiac Arrhythmias in the Setting of Dengue Virus Infection
  • Ethylene Glycol Intoxication (see Ethylene Glycol)
    • Physiology
      • Due to Calcium Oxalate Formation
  • Hydrofluoric Acid Toxicity (see Hydrofluoric Acid)
    • Epidemiology
      • Hypocalcemia is a Common Manifestation of Hydrofluoric Acid Toxicity (J Trauma, 1988) [MEDLINE]
    • Physiology
      • Fluoride Ions Bind to Calcium and Magnesium [LINK]
  • Postoperative Hypocalcemia
    • Physiology
      • Postoperative Hypocalcemia May Occur During or Soon After Surgery in Patients Who Have Received Large Amounts of Citrate-Containing Blood Products
      • Postoperative Hypocalcemia May Occur Even in Cases Where No Blood Products Have Been Given (J Clin Endocrinol Metab, 1999) [MEDLINE]
        • Due to Volume Expansion and Hypoalbuminemia
        • Ionized Calcium is Normal in Most (But Not All) of These Cases


Physiology

Major Factors Which Affect Serum Calcium Concentration

  • Parathyroid Hormone (PTH)
    • Parathyroid Hormone (PTH) is Secreted Almost Immediately in Response to a Small Decrease in the Ionized Calcium Concentration (Which is Sensed by the Calcium-Sensing Receptor/CaSR in the Parathyroid Gland)
      • PTH Increases Calcium Absorption in the Distal Tubule, Consequently Decreasing Renal Calcium Excretion
      • PTH Increases Bone Resorption of Calcium
      • PTH Increases Renal Production of 1,25-Dihydroxyvitamin D, Which Functions to Increase Intestinal Calcium Absorption
  • Vitamin D
    • Vitamin D is Enzymatically Converted in the Liver to 25-Hydroxyvitamin D (the Major Circulating Form of Vitamin D) and Then in the Kidney to 1,25-Dihydroxyvitamin D, the Active Form of Vitamin D
    • The Most Important Biological Function of Vitamin D is to Promote Enterocyte Differentiation and the Intestinal Absorption of Calcium
      • Lesser Stimulation of Intestinal Phosphate Absorption
      • Direct Suppression of Parathyroid Hormone (PTH) Release from the Parathyroid Gland
      • Regulation of Osteoblast Function
      • Permissively Allowing Parathyroid Hormone (PTH)-Induced Osteoclast Activation and Bone Resorption
  • Fibroblast Growth Factor 23 (FGF23)
    • Inhibits Renal Phosphate Reabsorption, Decreasing Serum Phosphate (Which Decreases Serum Calcium)
    • Inhibits Conversion of Vitamin D to its Active Form 1,25-Dihydroxyvitamin D (Calcitriol)
      • Decreases Calcium Absorption from Gastrointestinal Tract
    • Inhibits Parathyroid Hormone (PTH) Production
  • Calcium Ion Itself
    • Calcium Acts at the Calcium-Sensing Receptor (CaSR) in the Parthyroid Gland to Inhbit PTH Secretion
    • Calcium Acts at the Calcium-Sensing Receptor (CaSR) in the Loop of Henle to Stimulate Renal Calcium Excretion
  • Serum Phosphate Concentration

Mechanisms of Calcium Transport in the Blood (J Clin Invest, 1970) [MEDLINE] (Lancet, 1998) [MEDLINE]

  • Calcium Bound to Serum Proteins (Predominantly Albumin): 40-45%
  • Calcium Bound to Small Inorganic/Organic Anions (Phosphate, Citrate, Sulfate, Lactate, etc): 15%
  • Free (Ionized) Calcium: 40-45%
    • Ionized Calcium Concentration is Tightly Regulated by Parathyroid Hormone and Vitamin D
    • Only the Ionized Calcium is Metabolically Active (i.e. Transportable into Cells)

Relationship Between Total Serum Calcium Concentration and Ionized Calcium Concentration

General Comments

  • Normal Range of Total Serum Calcium Concentration (Varies by Laboratory): 8.5-10.5 mg/dL (2.12 to 2.62 mmol/L)
    • Wide Range of Normal Calcium Values is Accounted for by Individual Variations in the Serum Albumin Concentration and Hydration Status
    • Measurement of the Total Serum Calcium Concentration Can Be Misleading, Since There Can Be a Discordance Between Total Serum Calcium Concentration and Ionized Calcium Concentration (J Clin Endocrinol Metab, 1978) [MEDLINE]
  • Normal Range of Ionized Calcium Concentration (Adult): 1.16-1.31 mmol/L (4.65-5.25 mg/dL)
  • When Albumin and Other Serum Protein Concentrations Vary Significantly, Total Serum Calcium Levels May Vary
    • However, the Ionized Calcium Concentration (Which is Hormonally Regulated by Parathyroid Hormone and Vitamin D) Remains Relatively Stable

Conditions Which Decrease the Total Serum Calcium Concentration, But Do Not Change the Ionized Calcium Concentration

  • Hypoalbuminemia (see Hypoalbuminemia)
    • Total Serum Calcium Concentration Changes in Parallel to the Serum Albumin Concentration
      • In the Setting of Hypoalbuminemia (Due to Liver Disease, Renal Disease, etc), Total Serum Calcium Concentration Decreases
    • Historical Correction of Total Serum Calcium Concentration for Serum Albumin
      • Total Serum Calcium Decreases by Approximately 0.8 mg/dL (0.2 mmol/L) for Every 1.0 g/dL (10 g/L) Decrease in the Serum Albumin Concentration
      • Despite the Widespread Use of This Equation, the Accuracy of This Correction is Believed to Be Poor, Particularly in Patients with Critical Illness and Advanced Chronic Kidney Disease (Crit Care Med, 2003) [MEDLINE] (J Am Soc Nephrol, 2008) [MEDLINE] (Clin J Am Soc Nephrol, 2010) [MEDLINE] (Semin Dial, 2010) [MEDLINE] (Scand J Clin Lab Invest, 2017) [MEDLINE] (BMJ Open, 2018) [MEDLINE] (Clin Chem, 2018) [MEDLINE]
      • Poor Clinical Accuracy of This Equation May Be Explained by Metabolic Acidosis, Which Leads to an Underestimate of the Ionized Calcium Concentration
      • Some Studies Cite the Sensitivity of This Correction Equation at Only 5% (JPEN J Parenter Enteral Nutr, 2004) [MEDLINE]
    • More Modern Methods to Correct the Total Serum Calcium Concentration for Serum Albumin Have Not Been Widely Validated (and are Therefore, are Not Widely Used) (JPEN J Parenter Enteral Nutr, 2004) [MEDLINE] (Clin J Am Soc Nephrol, 2018) [MEDLINE] (J Appl Lab Med, 2020) [MEDLINE] (Clin Chim Acta, 2022) [MEDLINE]
    • Consequently, the Measurement of Ionized Calcium Remains the Gold Standard to Assess Calcium Status
    • If the Total Serum Calcium Concentration is Decreased, But the Ionized Calcium Concentration is Normal, This is Termed “Pseudohypocalcemia”

Conditions Which Increase the Total Serum Calcium Concentration, But Do Not Change the Ionized Calcium Concentration

  • Hyperalbuminemia (see Hyperalbuminemia)
    • Total Serum Calcium Concentration Changes in Parallel to the Serum Albumin Concentration
      • In the Setting of Hyperalbuminemia (Due to Extracellular Volume Deplteion, Fluid Movement Out of the Vascular Space, High Protein Diet, etc), Total Serum Calcium Concentration Increases
    • If the Total Serum Calcium Concentration is Increased, But the Ionized Calcium Concentration is Normal, This is Termed “Pseudohypercalcemia”
  • Multiple Myeloma (see Multiple Myeloma)
    • In Some Cases, a Monoclonal Myeloma Protein Can Bind to Calcium with High Affinity, Increasing the Total Serum Calcium Concentration
      • Since Multiple Myeloma Can Cause True Hypercalcemia Due to Osteolytic Bone Metastases, Measuring an Ionized Calcium is Nescssary to Aid in the Diagnosis This Entity
      • Hyperproteinemia Can Also Cause a Spurious Increase in Serum Phsophate Concentration (see Hyperphosphatemia) (BMJ, 1989) [MEDLINE]
        • Due to Interference with the Molybdate Assay Used to Measure the Serum Phosphate Concentration

Conditions Which Decrease the Ionized Calcium Concentration, But Do Not Change the Total Serum Calcium Concentration

  • Acute Respiratory Alkalosis/Hyperventilation (see Acute Respiratory Alkalosis and Hyperventilation)
    • Mechanism
      • Alkalemia Increases the Calcium Binding to Albumin, Decreasing the Ionized Calcium Concentration (Eur J Clin Invest, 1982) [MEDLINE]
        • Decrease in Ionized Calcium Concentration is Approximately 0.16 mg/dL (0.04 mmol/L or 0.08 mEq/L) for Each 0.1 Unit Increase in the pH
    • Clinical
      • For This Reason, Hyperventilation with Acute Respiratory Alkalosis Can Result in Clinical Symptoms of Hypocalcemia (Such as Muscle Cramps, Paresthesias, Tetany, and Seizures)
      • Similarly, In Vitro Changes in the pH in Whole Blood or Serum Laboratory Specimens Can Result in Changes in the Ionized Calcium Concentration (Lab Med, 2002) [MEDLINE]
      • In the Setting of Chronic Kidney Disease (CKD) with Coexisting Underlying Hypocalcemia, Bicarbonate Therapy (or Dialysis) Can Increase the Serum pH, Resulting in a Decreased Ionized Calcium Concentration and Clinical Symptoms of Hypocalcemia (Am J Kidney Dis, 1997) [MEDLINE] (Nephron, 2001) [MEDLINE]
  • Chronic Respiratory Alkalosis (see Acute Respiratory Alkalosis)
    • Mechanism
      • Although the Mechanism is Unclear, It Appears to Be Due to Relative Hypoparathyroidism and Renal Resistance to Parathyroid Hormone (PTH) with Resultant Hypercalciuria, Decreasing the Ionized Calcium Concentration (Kidney Int, 1992) [MEDLINE]
  • Acute Hyperphosphatemia (Due to Cellular Breakdown with Phosphate Release) (see Hyperphosphatemia)
    • Mechanism
      • Released Phosphate Binds to Circulating Calcium, Decreasing the Ionized Calcium Concentration
        • In Addition, in a Short Period of Time, Calcium-Phosphate Precipitates and Deposits in Soft Tissues, Additionally Resulting in a Decreased Total Serum Calcium Concentration

Conditions Which Increase the Ionized Calcium Concentration, But Do Not Change the Total Serum Calcium Concentration

  • Chronic Metabolic Acidosis (see Metabolic Acidosis-General) (J Am Soc Nephrol, 2008) [MEDLINE] (Clin J Am Soc Nephrol, 2010) [MEDLINE]
    • Mechanism
      • Acidemia Decreases Calcium Binding to Albumin, Increasing the Ionized Calcium Concentration
  • Parathryoid Hormone (PTH)
    • Mechanism
      • Parathyroid Hormone Decreases Calcium Binding to Albumin, Increasing the Ionized Calcium Concentration (J Clin Endocrinol Metab, 1979) [MEDLINE]
        • However, Since Sensitivities of Total Serum Calcium Concentration and Ionized Calcium Concentration were the Same in the Diagnosis of Primary Hyperparathyrodism, the Effect of PTH on Protein Binding of Calcium May Not Have Clinical Significance (Clin Biochem, 2011) [MEDLINE]


Diagnosis

Serum Calcium (see Serum Calcium)

Normal Range of Serum Calcium

  • Normal Range (Varies by Laboratory): 8.5-10.5 mg/dL (2.12 to 2.62 mmol/L)
    • Level Below the Lower End of this Normal Range is Considered Hypocalcemia
    • Wide Range of Normal Calcium Values is Accounted for by Individual Variations in the Serum Albumin Concentration and Hydration Status
    • Measurement of the Total Serum Calcium Concentration Can Be Misleading, Since There Can Be a Discordance Between Total Serum Calcium Concentration and Ionized Calcium Concentration (J Clin Endocrinol Metab, 1978) [MEDLINE]

Ionized Calcium

Normal Range of Ionized Calcium

  • Normal Range: 1.16 to 1.31 mmol/L (4.65 to 5.25 mg/dL)


Clinical Manifestations

Acute Hypocalcemia

Cardiovascular Manifestations

  • Arrhythmias
    • Physiology
      • Hypocalcemia (Frequently Seen in the Setting of Chronic Kidney Disease) Results in ST Segment Prolongation and QT Interval Prolongation (J Emerg Med, 2004) [MEDLINE] (Cardiol J, 2011) [MEDLINE]
    • Clinical
      • Torsades de Pointes (Polymorphic Ventricular Tachycardia Associated with a QT Prolongation) Can Be Triggered by Hypocalcemia, But Occurs Far Less Frequently than it Does in the Setting of Hypokalemia or Hypomagnesemia
      • Although Electrocardiographic Conduction Abnormalities are Common, Serious Hypocalcemia-Induced Arrhythmias (Heart Block, Ventricular Arrhythmias, etc), are Uncommon
  • Congestive Heart Failure (CHF)/Myocardial Dysfunction (see Congestive Heart Failure)
    • Epidemiology
      • Cases of Hypocalcemia-Associated Heart Failure Have Been Extensively Reported (Anesth Analg, 1976) [MEDLINE] (Am J Med, 1985) [MEDLINE] (Am J Nephrol, 1990) [MEDLINE] (Nephron, 1992) [MEDLINE] (Am J Kidney Dis, 1994) [MEDLINE] (Clin Nephrol, 2006) [MEDLINE] (Am J Med Sci, 2007) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE]
    • Physiology
      • Myocardial Dysfunction
        • Calcium Plays a Critical Role in Excitation-Contraction Coupling
        • Calcium is Required for Epinephrine-Induced Cardiac Glycogenolysis
    • Treatment
      • Hypocalcemia-Associated Myocardial Dysfunction is Reversible with Calcium Replacement (Am Heart J, 1985) [MEDLINE] (Am Heart J, 1990) [MEDLINE]
  • Hypotension (see Hypotension)
    • Epidemiology
      • Cases of Hypocalcemia-Associated Hypotension Have Been Extensively Reported (Am J Kidney Dis, 1994) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE] (Hemodial Int, 2016) [MEDLINE]
      • Hypocalcemia-Associated Hypotension is Most Commonly Seen When it is Rapidly Induced by Ethylenediaminetetraacetic Acid (EDTA), Transfusion of Citrated Blood Products, or with the Use of Low Calcium Dialysate in Patients Undergoing Dialysis (Anesth Analg, 1976) [MEDLINE] (Am J Kidney Dis, 1994) [MEDLINE] (Am J Kidney Dis, 2015) [MEDLINE] (Hemodial Int, 2016) [MEDLINE]
      • Hypocalcemia-Induced Hypotension May Be Observed During Continuous Renal Replacement Therapy (CRRT) (J Crit Care, 2021) [MEDLINE]
    • Physiology
      • Calcium is Required for Vascular Smooth Muscle Contractility (Microcirculation, 2013) [MEDLINE]
    • Clinical
  • QT Interval Prolongation with Increased Risk of Torsade (see Torsade)
    • Physiology
      • Hypocalcemia (Frequently Seen in the Setting of Chronic Kidney Disease) Results in ST Segment Prolongation and QT Interval Prolongation (J Emerg Med, 2004) [MEDLINE] (Eur J Cardiovasc Prev Rehabil, 2005) [MEDLINE] (J Electrocardiol, 2007) [MEDLINE] (Cardiol J, 2011) [MEDLINE]
      • Hypocalcemia Prolongs Phase 2 of the Action Potential (with the Impact Modulated by the Rate of CHange of Serum Calcium Concentration and Function of the Myocyte Calcium Channels)
      • QT Prolongation is Associated with Early After-Depolarizations and Triggered Arrhythmias
    • Clinical
      • Torsades de Pointes (Polymorphic Ventricular Tachycardia Associated with a QT Prolongation) Can Be Triggered by Hypocalcemia, But Occurs Far Less Frequently than it Does in the Setting of Hypokalemia or Hypomagnesemia
      • Although Electrocardiographic Conduction Abnormalities are Common, Serious Hypocalcemia-Induced Arrhythmias (Heart Block, Ventricular Arrhythmias, etc), are Uncommon
  • ST-Segment Elevation (Mimicking ST Elevation Myocardial Infarction)
    • Epidemiology
      • Case Report (Cardiol J, 2022) [MEDLINE]
  • Syncope (see Syncope)
    • Epidemiology
      • May Occur

Neuropsychiatric Manifestations

  • Altered Mental Status
    • Clinical
      • General Comments
        • Confusion/Delirium, Hallucinations, and Psychosis are All Less Common Clinical Features of Hypocalcemia
      • Confusion/Delirium (see Delirium)
      • Hallucinations (see Hallucinations)
      • Psychosis (see Psychosis)
    • Treatment
      • Altered Mental Status is Reversible with Calcium Replacement
  • Anxiety/Depression/Emotional Instability (see Anxiety and Depression)
    • Epidemiology
      • May Occur
    • Treatment
      • Anxiety/Depression/Emotional Instability are Reversible with Calcium Replacement
  • Fatigue (see Fatigue)
    • Epidemiology
      • May Occur
  • Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) (see Pseudotumor Cerebri)
    • Epidemiology
      • Papilledema is Most Commonly Observed in the Setting of Acute Hypercalcemia
    • Clinical
      • Papilledema (see Papilledema)
        • Papilledema Can Occur in Hypocalcemia of Any Etiology (Neurology, 1976) [MEDLINE] (J Pediatr, 1977) [MEDLINE] (Can J Neurol Sci, 1987) [MEDLINE]
        • Papilledema Occurs Only with Severe Hypocalcemia
        • Papilledema May or May Not Be Accompanied by Increased Cerebrospinal Fluid Pressure (Benign Intracranial Hypertension)
    • Treatment
      • Papilledema is Reversible with Calcium Replacement
  • Neuromuscular Irritability (Tetany) (see Tetany)
    • Epidemiology
      • Tetany is Most Commonly Observed in the Setting of Acute Hypercalcemia
      • Patients with a Gradual Decline in Serum Calcium Tend to Have Fewer Symptoms at the Same Calcium Level than Patients with Acute Hypocalcemia (Endocrinol Metab Clin North Am, 1993) [MEDLINE]
      • Tetany Usually Only Occurs when Ionized Calcium Falls to Below 1.10 mmol/L (Corresponding to a Total Serum Calcium of Approximately 7-7.5 mg/dL)
    • Physiology
      • Acute Hypocalcemia Increases Neuromuscular Irritability (Brain, 1991) [MEDLINE]
        • Hyperexcitability Occurs at Central Nervous System Level, Spinal Reflex Level, and Motor Endplate Level
      • Hypocalcemia and Alkalosis Act Synergistically to Cause Tetany (see Metabolic Alkalosis] and Respiratory Alkalosis)
        • Respiratory Alkalosis Can Cause Tetany Even in the Absence of Hypocalcemia
    • Diagnosis
    • Clinical
      • General Comments
        • Tetany Manifests as Both Sensory and Motor Dysfunction (Endocrinol Metab Clin North Am, 1993) [MEDLINE]
      • Autonomic Manifestations
      • Chvostek Sign (see Chvostek Sign)
        • Tapping of the Facial Nerve Hust Anterior to the Ear Elicits Contraction of the Ipsilateral Facial Muscles
        • Sensitivity of Chvostek Sign for Hypocalcemia: 29%
        • Chvostek Sign Occurs in Approximately 10% of Normal Subjects
      • Clumsiness
      • Hyperreflexia (see Hyperreflexia)
      • Laryngospasm (Laryngismus Stridulus) (see Laryngospasm) (J Emerg Med, 2015) [MEDLINE] (BMJ Case Rep, 2018) [MEDLINE] (Front Horm Res, 2019) [MEDLINE]
      • Muscle Cramps (see Muscle Cramps)
      • Muscle Spasms/Twitching
      • Myalgias (see Myalgias)
      • Perioral/Acral Paresthesias (see Paresthesias)
        • These Symptoms Can Cause Hyperventilation, Resulting in Respiratory Alkalosis, Which Exacerbates the Paresthesias
      • Stiffness
      • Trousseau Sign (see Trousseau Sign)
        • Other Name for Sign: “main d’accoucheur” (French for “hand of the obstetrician”) because it resembles the position of an obstetrician’s hand in delivering a baby
        • Inflated Blood Pressure Cuff for 3 min Elicits Carpopedal Spasm in the Hand/Forearm
        • Sensitivity for Hypocalcemia: 94%
  • Optic Neuritis (see Optic Neuritis)
    • Epidemiology
      • Rarely, Optic Neuritis Occurs Instead of Papilledema (Neurology, 1976) [MEDLINE]
    • Clinical
      • Decreased Visual Acuity
  • Seizures (see Seizures)
    • Epidemiology
      • Seizures are Most Commonly Observed in the Setting of Acute Hypercalcemia
    • Physiology
      • Low Cerebrospinal Fluid Ionized Calcium Concentrations May Have a Convulsive, But Not a Direct Tetanic Effect (Arch Neurol, 1973) [MEDLINE]
        • This Explains Hypocalcemia-Associated Seizures in the Absence of Tetany
    • Diagnosis
      • Electroencephalogram (EEG) (see Electroencephalogram)
        • In Hypocalcemia-Associated Seizures, the Electroencephalogram (EEG) Demonstrates Both Spikes (“Convulsive Effect”) and Bursts of High-Voltage, Paroxysmal Slow Waves (Arch Neurol, 1972) [MEDLINE]
    • Clinical
      • General Comments
        • Seizures May Be the Sole Presenting Symptom (Clin EEG Neurosci, 2004) [MEDLINE] (Epileptic Disord, 2004) [MEDLINE]
      • Focal Seizures
      • Generalized Tonic-Clonic Seizures
      • Generalized Absence Seizures

Chronic Hypocalcemia

Dermatologic Manifestations

  • Xerosis Cutis/Xeroderma (Dry Skin) (see Xerosis)
    • Epidemiology
      • Most Commonly Associated with Chronic Hypocalcemia

Hematologic Manifestations

  • Macrocytic Anemia (see Anemia)
    • Diagnostic
      • Abnormal Schilling Test

Neuropsychiatric Manifestations

Ophthalmologic Manifestations

  • Subcapsular Cataracts (see Cataracts)
    • Epidemiology
      • Most Commonly Associated with Chronic Hypocalcemia
      • Frequently Associated with Hypoparathyroidism-Associated Hypocalcemia (see Hypoparathyroidism)

Rheumatologic Manifestations

Other Manifestations

  • Abnormal Dentition
    • Epidemiology
      • Most Commonly Associated with Chronic Hypocalcemia


Treatment

Oral Calcium Replacement

Intravenous Calcium Replacement

  • Clinical Efficacy
    • Systematic Review of Parenteral Calcium Replacement in Critical Care Patients (Cochrane Database Syst Rev, 2008) [MEDLINE]: no evidence that parenteral calcium replacement improves outcome in critically ill patients
  • Agents
    • Calcium Chloride (in 10 ml = 10%) (see Calcium Chloride): 1 amp over 30-60 min
    • Calcium Gluconate (see Calcium Gluconate): 1 amp IV over 30-60 min
      • Avoid Use in Liver Disease
  • Adverse Effects
    • Carpopedal Spasm: with rapid infusion


References

Etiology

Physiology

Clinical Manifestations

Cardiovascular

Laryngospasm (see Laryngospasm)

Neurologic

Seizures

Other

Treatment